Search Login Register

Neonatal Jaundice Summary

Description: Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.

Also Known As: Jaundice, Neonatal; Icterus Gravis Neonatorum; Physiological Neonatal Jaundice; Severe Jaundice in Neonate; Severe Jaundice in Newborn Show All >>

Networked: 732 relevant articles (30 outcomes, 78 trials/studies) for this Disease

Key Drugs and Agents for Neonatal Jaundice

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Bilirubin : 3 outcomes 24 studies in 204 results : IBA
  2. tin protoporphyrin IX : 2 outcomes in 7 results : IBA
  3. Clofibrate : 2 outcomes in 6 results : FDA 6
  4. Metalloporphyrins : 1 outcome 2 studies in 9 results : IBA
  5. Vitamin E : 1 outcome 1 study in 3 results : FDA 13 Generic
  6. Intravenous Immunoglobulins (IVIG) : 1 outcome 1 study in 1 result : FDA 1
  7. tin mesoporphyrin : 1 outcome 1 study in 1 result : IBA
  8. Porphyrins : 1 outcome in 3 results : IBA
  9. Nifedipine (Adalat) : 1 outcome in 2 results : FDA 25 Generic
  10. Metformin (Glucophage) : 1 outcome in 2 results : FDA 4 Generic
Show All >>

Diseases Related to Neonatal Jaundice

  1. Glucosephosphate Dehydrogenase Deficiency
  2. Infertility (Sterility)
  3. Hemorrhage
  4. Toxemia
  5. Rubella (German Measles)
Show All >>

Key Therapies for Neonatal Jaundice

Efficacy Chart >>
  1. Phototherapy (Light Therapy) : 15 outcomes 16 studies in 195 results
  2. Neonatal Intensive Care : 1 outcome 2 studies in 6 results
  3. Massage (Reflexology) : 1 outcome 1 study in 3 results
  4. Hemoperfusion : 1 outcome 1 study in 1 result
  5. Aftercare (After-Treatment) : 1 outcome in 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.